EUVIMEDEUVIMED entdecken
Open Access

Small molecule telomerase inhibitors are also potent inhibitors of telomeric C-strand synthesis

Kaitlin Johnson iD, Julia M Seidel, Thomas R Cech iD

RNA · 2024

DOI: 10.1261/rna.080043.124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RNA, 2024. Verfasst von Kaitlin Johnson und 2 weiteren Autor:innen. Beteiligte Einrichtung: BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado 80303, USA. Hauptthemen laut MEDLINE: Telomerase, Telomere, G-Quadruplexes, Enzyme Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCRR NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telomere replication is essential for continued proliferation of human cells, such as stem cells and cancer cells. Telomerase lengthens the telomeric G-strand, while C-strand replication is accomplished by CST–polymerase α–primase (CST–PP). Replication of both strands is inhibited by formation of G-quadruplex (GQ) structures in the G-rich single-stranded DNA. TMPyP4 and pyridostatin (PDS), which stabilize GQ structures in both DNA and RNA, inhibit telomerase in vitro, and in human cells they cause telomere shortening that has been attributed to telomerase inhibition. Here, we show that TMPyP4 and PDS also inhibit C-strand synthesis by stabilizing DNA secondary structures and thereby preventing CST–PP from binding to telomeric DNA. We also show that these small molecules inhibit CST–PP binding to a DNA sequence containing no consecutive guanine residues, which is unlikely to form GQs. Thus, while these “telomerase inhibitors” indeed inhibit telomerase, they are also robust inhibitors of telomeric C-strand synthesis. Furthermore, given their binding to GQ RNA and their limited specificity for GQ structures, they may disrupt many other protein–nucleic acid interactions in human cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseTelomereG-QuadruplexesEnzyme InhibitorsHumansPicolinic AcidsDNA ReplicationDNA Polymerase IDNAAminoquinolinesPorphyrinsDNA Primase

Stichwörter der Autor:innen

G-quadruplexGQ stabilizersTMPyP4pyridostatintelomere replication

Substanzen

TelomerasepyridostatinEnzyme InhibitorsPicolinic Acidstetra(4-N-methylpyridyl)porphineDNA polymerase alpha-primaseDNA Polymerase IDNAAminoquinolinesPorphyrins

Autor:innen und Institutionen

  • BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado 80303, USA.
  • Department of Biochemistry, University of Colorado Boulder, Boulder, Colorado 80303, USA.
  • Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, Colorado 80303, USA.
  • BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado 80303, USA thomas.cech@colorado.edu.

ORCID-Profile: Kaitlin Johnson, Thomas R Cech

Förderung

  • NCRR NIH HHS
  • National Institutes of Health

Zitieren

APA

Johnson, K., Seidel, J. M., & Cech, T. R. (2024). Small molecule telomerase inhibitors are also potent inhibitors of telomeric C-strand synthesis. RNA. https://doi.org/10.1261/rna.080043.124

Vancouver

Johnson K, Seidel JM, Cech TR. Small molecule telomerase inhibitors are also potent inhibitors of telomeric C-strand synthesis. RNA. 2024. doi:10.1261/rna.080043.124

BibTeX
@article{Johnson2024,
  author = {Johnson, Kaitlin and Seidel, Julia M and Cech, Thomas R},
  title = {Small molecule telomerase inhibitors are also potent inhibitors of telomeric C-strand synthesis},
  journal = {RNA},
  year = {2024},
  doi = {10.1261/rna.080043.124}
}
Kostenlos starten →